Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

ChemUK 2025

CHEMUK 2025 is the UK’s leading trade show for professionals in the chemicals, process engineering, and formulated product industries. Across two days, attendees can explore [...]

Go to Top